Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
Clinical trial NCT00275054 · COMPLETED
Trial details
- NCT number
- NCT00275054
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-07-01
- Enrollment
- 825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.